Table 1. Comparison of groups with each other before treatment.
| Group 1 | Group 2 | p | |
|---|---|---|---|
| (n=34) | (n=34) | ||
| Age, years (Mean ± SD) | 46.5 ± 9.9 | 43.1 ± 7.2 | 0.708† |
| BMI, kg/m2 (Mean ± SD) | 24.8 ± 2.2 | 24.5 ± 2.2 | 0.896† |
| 24-hour frequency (Mean ± SD) | 11.2 ± 2.1 | 11.2 ± 2.0 | 0.830 |
| Average voided volume, mL (Mean ± SD) | 252.2 ± 81.7 | 261.4 ± 94.4 | 0.668 |
| Qmax, mL/s, (Mean ± SD) | 11.0 ± 2.7 | 11.1 ± 2.6 | 0.964 |
| Qave, mL/s (Mean ± SD) | 6.0 ± 1.1 | 6.0 ± 1.1 | 0.918 |
| PVR, mL (Mean ± SD) | 83.2 ± 25.4 | 82.7 ± 24.8 | 0.942 |
| UDI-6 score (Median) | 13.5 | 13.5 | 0.995 |
| EMG activity, n (%) | 34 (100) | 34 (100) | 1†† |
BMI = Body mass index;Qmax:maximum urine flow rate; Qave = average urine flow rate; PVR = Post-void residual urine volume; UDI-6 = Urogenital Distress Inventory; EMG = electromyography
†
Kruskal Wallis
††
Intergroup comparison was performed using the Chi-square test